Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
No Data
Morgan Stanley Maintains Prime Medicine(PRME.US) With Hold Rating
Analysts Conflicted on These Healthcare Names: Kyverna Therapeutics, Inc. (KYTX), Immunome (IMNM) and Prime Medicine, Inc. (PRME)
Prime Medicine (PRME) Reports Q1 EPS
Oppenheimer Maintains Prime Medicine(PRME.US) With Buy Rating, Announces Target Price $11
Chardan Capital Maintains Prime Medicine(PRME.US) With Buy Rating, Maintains Target Price $9
JonesTrading Initiates Prime Medicine(PRME.US) With Buy Rating, Announces Target Price $5